These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3120354)

  • 21. The modification of macrophage activity in experimental granulomas by cyclophosphamide.
    Birman EG; Mariano M
    J Pathol; 1981 Jun; 134(2):133-46. PubMed ID: 7252645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
    Tzai TS; Lin JS; Chow NH
    J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II].
    Perito S; Cenci E; Sbaraglia G; Vecchiarelli A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2511-7. PubMed ID: 7470294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs].
    Matsuzaki T; Kato I; Yokokura T; Mutai M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):445-51. PubMed ID: 6200079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice.
    Moriya N; Miwa H; Orita K
    Jpn J Surg; 1984 Mar; 14(2):163-6. PubMed ID: 6379248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The immunomodulation of the natural killer activity of the splenocytes in C3HA mice during hepatoma 22a growth].
    Filatova NA; Malygin AM; Goriunova LB; Fel' VIa; Khavinson VKh
    Tsitologiia; 1990; 32(6):652-8. PubMed ID: 2238117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide.
    Liu DF; Wei W; Song LH
    Acta Pharmacol Sin; 2006 Apr; 27(4):460-8. PubMed ID: 16539847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide.
    Nakajima H; Hashimoto S; Kita Y; Takashi T; Tsukada W; Kohno M; Ogawa H; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Dec; 53(6):263-9. PubMed ID: 6240552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for host-mediated antitumor activity in the treatment of experimental tumor with a hot water extract from BCG.
    Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1982 Jan; 136(1):67-74. PubMed ID: 7071830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
    Futami H; Jansen R; MacPhee MJ; Keller J; McCormick K; Longo DL; Oppenheim JJ; Ruscetti FW; Wiltrout RH
    J Immunol; 1990 Dec; 145(12):4121-30. PubMed ID: 2258610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain variation in BCG-induced chronic pulmonary inflammation in mice: control by a cyclophosphamide-sensitive thymus-derived suppressor cell.
    Moore VL; Mondloch VM; Pedersen GM; Schrier DJ; Allen EM
    J Immunol; 1981 Jul; 127(1):339-42. PubMed ID: 6453897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW; Mokyr MB
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
    Abe S; Yoshioka O; Masuko Y; Tsubouchi J; Kohno M; Nakajima H; Yamazaki M; Mizono D
    Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide.
    Stuehr DJ; Marletta MA
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7738-42. PubMed ID: 3906650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.